WELLS FARGO & COMPANY/MN
Position in ABOS — Acumen Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in ABOS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$132,661
+$108,807 QoQ
Shares Held
49,686
+391.6% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 96 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. ABOS ranks #275 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ABOS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,661 | 49,686 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $23,854 | 10,108 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $14,981 | 7,100 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,115 | 6,500 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,917 | 6,825 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $30,445 | 27,678 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $44,924 | 26,119 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $52,719 | 21,258 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $49,443 | 20,431 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,892 | 1,208 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $8,467 | 2,205 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $805 | 194 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,105 | 2,101 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $12,569 | 3,096 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,681 | 1,793 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $20,962 | 2,090 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,679 | 570 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,842 | 2,773 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,027 | 2,075 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $757 | 51 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||